{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:50:42Z","timestamp":1789051842603,"version":"build-2803163510"},"reference-count":223,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.pharmthera.2005.06.019","type":"journal-article","created":{"date-parts":[[2005,8,16]],"date-time":"2005-08-16T11:12:51Z","timestamp":1124190771000},"page":"339-365","source":"Crossref","is-referenced-by-count":111,"title":["Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism"],"prefix":"10.1016","volume":"109","author":[{"given":"Nobuo","family":"Nagano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2005.06.019_bib1","unstructured":"Amgen Inc. (2004). Sensipar\u2122 (cinacalcet HCl) tablets: sensipar's prescribing information. Available at: http:\/\/www.sensipar.com."},{"key":"10.1016\/j.pharmthera.2005.06.019_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1523-1755.1998.00735.x","article-title":"A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure","volume":"53","author":"Antonsen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000180515","article-title":"Kidney and calcitonin","volume":"15","author":"Ardaillou","year":"1975","journal-title":"Nephron"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0272-6386(99)70302-1","article-title":"Risk factors for vertebral fractures in renal osteodystrophy","volume":"33","author":"Atsumi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib5","doi-asserted-by":"crossref","first-page":"34871","DOI":"10.1074\/jbc.M100775200","article-title":"Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein","volume":"276","author":"Awata","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib6","doi-asserted-by":"crossref","first-page":"23605","DOI":"10.1074\/jbc.273.36.23605","article-title":"Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells","volume":"273","author":"Bai","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1677\/joe.1.05565","article-title":"The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone\u2013calcium curve","volume":"184","author":"Bas","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib8","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"230","article-title":"Primary hyperparathyroidism","author":"Bilezikian","year":"2003"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib10","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib11","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib12","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1210\/en.130.3.1339","article-title":"Phospholipase-A2 action and arachidonic acid metabolism in calcium-mediated parathyroid hormone secretion","volume":"130","author":"Bourdeau","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/en.135.3.1109","article-title":"Effects of lipoxygenase products of arachidonate metabolism on parathyroid hormone secretion","volume":"135","author":"Bourdeau","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib14","doi-asserted-by":"crossref","first-page":"18382","DOI":"10.1074\/jbc.274.26.18382","article-title":"The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain","volume":"274","author":"Br\u00e4uner-Osborne","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0272-6386(97)90484-4","article-title":"Effects of excess PTH on nonclassical target organs","volume":"30","author":"Bro","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/jcem-56-3-572","article-title":"Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue","volume":"56","author":"Brown","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1152\/physrev.1991.71.2.371","article-title":"Extracellular Ca2+-sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers","volume":"71","author":"Brown","year":"1991","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","article-title":"Extracellular calcium sensing and extracellular calcium signaling","volume":"81","author":"Brown","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1006\/bbrc.1995.2048","article-title":"Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression","volume":"212","author":"Brown","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib21","doi-asserted-by":"crossref","first-page":"F454","DOI":"10.1152\/ajprenal.1996.270.3.F454","article-title":"Rat calcium-sensing receptor is regulated by vitamin D but not by calcium","volume":"270","author":"Brown","year":"1996","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib22","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1046\/j.1523-1755.1999.00386.x","article-title":"Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate","volume":"55","author":"Brown","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib23","doi-asserted-by":"crossref","first-page":"30337","DOI":"10.1074\/jbc.M201804200","article-title":"Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D","volume":"277","author":"Canaff","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib24","doi-asserted-by":"crossref","first-page":"14177","DOI":"10.1074\/jbc.M408587200","article-title":"Calcium-sensing receptor gene transcription is up-regulated by the proinflammatory cytokine, interleukin-1\u03b2: role of the NF-\u03baB pathway and \u03baB elements","volume":"280","author":"Canaff","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib25","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1210\/jc.85.12.4789","article-title":"Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca2+ set-point in patients with primary hyperparathyroidism","volume":"85","author":"Cetani","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1158\/0008-5472.493.65.2","article-title":"Calcium sensing receptor in human colon carcinoma: interaction with Ca2+ and 1,25-dihydroxyvitamin D3","volume":"65","author":"Chakrabarty","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ki.1985.27","article-title":"Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients","volume":"27","author":"Charhon","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib28","first-page":"289","article-title":"The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism","volume":"17","author":"Chattopadhyay","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib29","doi-asserted-by":"crossref","first-page":"G122","DOI":"10.1152\/ajpgi.1998.274.1.G122","article-title":"Identification and localization of the extracellular Ca2+-sensing receptor in rat intestine","volume":"274","author":"Chattopadhyay","year":"1998","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.V115903","article-title":"Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats","volume":"11","author":"Chin","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib31","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJM198405103101904","article-title":"The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects","volume":"310","author":"Cholst","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrd746","article-title":"Allosteric binding sites on cell-surface receptors: novel targets for drug discovery","volume":"1","author":"Christopoulos","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jemt.1070320210","article-title":"Ultrastructure of human parathyroid cells in health and disease","volume":"32","author":"Cinti","year":"1995","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib35","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jc.83.4.1083","article-title":"Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent","volume":"83","author":"Collins","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","article-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism","volume":"67","author":"Colloton","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib37","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/sj.ejcn.1601463","article-title":"l-Amino acid sensing by the calcium-sensing receptor: a general mechanism for coupling protein and calcium metabolism?","volume":"56","author":"Conigrave","year":"2002","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib38","doi-asserted-by":"crossref","first-page":"38151","DOI":"10.1074\/jbc.M406373200","article-title":"l-Amino acids regulate parathyroid hormone secretion","volume":"279","author":"Conigrave","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib39","series-title":"ERA-EDTA XLI Congress Abstract Book","first-page":"219","article-title":"The effect of cinacalcet HCl on parathyroidectomy, fracture, hospitalization, and mortality in dialysis subjects with secondary hyperparathyroidism (HPT)","author":"Cunningham","year":"2004"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib40","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0960-894X(00)00382-6","article-title":"N1-arylsulfonyl-N2-(1-aryl)ethyl-3-phenylpropane-1,2-diamines as novel calcimimetics acting on the calcium sensing receptor","volume":"10","author":"Dauban","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib41","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0272-6386(96)90473-4","article-title":"Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure","volume":"28","author":"Denda","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ki.1995.292","article-title":"The pathogenesis of parathyroid gland hyperplasia in chronic renal failure","volume":"48","author":"Dr\u00fceke","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib43","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.V1161141","article-title":"Cell biology of parathyroid gland hyperplasia in chronic renal failure","volume":"11","author":"Dr\u00fceke","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib44","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1359\/jbmr.2002.17.12.2094","article-title":"Pathophysiology and recent advances in the management of renal osteodystrophy","volume":"17","author":"Elder","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI114979","article-title":"On the mechanism of impaired insulin secretion in chronic renal failure","volume":"87","author":"Fadda","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib46","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1210\/jc.82.10.3481","article-title":"Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism","volume":"82","author":"Farnebo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib47","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ndt\/12.5.933","article-title":"Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans","volume":"12","author":"Fliser","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/ENDO:10:2:97","article-title":"The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism","volume":"10","author":"Fox","year":"1999","journal-title":"Endocrine"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib49","first-page":"480","article-title":"Calcimimetic compound NPS R-568 stimulates calcitonin secretion but selectively targets parathyroid gland Ca2+ receptor in rats","volume":"290","author":"Fox","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib50","first-page":"473","article-title":"NPS R-568: a type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium","volume":"290","author":"Fox","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib51","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1210\/en.137.9.3842","article-title":"Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion","volume":"137","author":"Freichel","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib52","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0006-291X(02)00405-9","article-title":"Functional GABAB receptors expressed in cultured calvarial osteoblasts","volume":"293","author":"Fujimori","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib53","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib54","doi-asserted-by":"crossref","first-page":"C1168","DOI":"10.1152\/ajpcell.1997.273.4.C1168","article-title":"Ca2+-sensing receptors in intestinal epithelium","volume":"273","author":"Gama","year":"1997","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib55","doi-asserted-by":"crossref","first-page":"39053","DOI":"10.1074\/jbc.M105662200","article-title":"Heterodimerization of calcium sensing receptors with metabotropic glutamate receptors in neurons","volume":"276","author":"Gama","year":"2001","journal-title":"J Biol Chem"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2005.06.019_bib56","first-page":"S387","article-title":"The calcium receptor agonist R-568 suppresses PTH mRNA levels in cultured bovine parathyroid cells","volume":"10","author":"Garrett","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib57","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1210\/en.136.11.5202","article-title":"Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene","volume":"136","author":"Garrett","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib58","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int"},{"issue":"Suppl. 85","key":"10.1016\/j.pharmthera.2005.06.019_bib59","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1046\/j.1523-1755.63.s85.10.x","article-title":"Effect of aluminum on calcium-sensing receptor expression, proliferation, and apoptosis of parathyroid glands from rats with chronic renal failure","volume":"63","author":"Gonz\u00e1lez-Su\u00e1rez","year":"2003","journal-title":"Kidney Int"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2005.06.019_bib60","first-page":"iii2","article-title":"Medical management of secondary hyperparathyroidism in chronic renal failure","volume":"18","author":"Goodman","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib61","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/ki.1996.503","article-title":"In vivo assessments of calcium-regulated parathyroid hormone release in secondary hyperparathyroidism","volume":"50","author":"Goodman","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib62","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1523-1755.2000.00183.x","article-title":"A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism","volume":"58","author":"Goodman","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib63","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib64","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib65","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF01655421","article-title":"The effect of intravenous magnesium sulphate on parathyroid function in primary hyperparathyroidism","volume":"12","author":"Gough","year":"1988","journal-title":"World J Surg"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib66","first-page":"1083","article-title":"Allosteric activation of the Ca2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568","volume":"53","author":"Hammerland","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib67","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0026-895X(24)23025-X","article-title":"Domains determining ligand specificity for Ca2+ receptors","volume":"55","author":"Hammerland","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib68","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.ajkd.2004.08.029","article-title":"Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily","volume":"44","author":"Harris","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib69","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1210\/en.141.11.4156","article-title":"Effects of a calcimimetic compound and naturally activating mutations on the human Ca2+ receptor and on Ca2+ receptor\/metabotropic glutamate chimeric receptors","volume":"141","author":"Hauache","year":"2000","journal-title":"Endocrinology"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2005.06.019_bib70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ndt\/11.supp3.11","article-title":"Parathyroid gland calcium receptor gene expression is not regulated by increased dietary phosphorus in normal and renal failure rats","volume":"11","author":"Hern\u00e1ndez","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2362.1974.tb00395.x","article-title":"Human calcitonin radioimmunoassay in normal and pathological conditions","volume":"4","author":"Heynen","year":"1974","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib72","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0140-6736(76)91973-5","article-title":"Evidence that endogenous calcitonin protects against renal bone disease","volume":"308","author":"Heynen","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib73","doi-asserted-by":"crossref","first-page":"34880","DOI":"10.1074\/jbc.M100784200","article-title":"Filamin-A binds to the carboxyl-terminal trail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase","volume":"276","author":"Hj\u00e4lm","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib74","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ng1295-389","article-title":"A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"11","author":"Ho","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib75","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1073\/pnas.0405516101","article-title":"Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification","volume":"101","author":"Hough","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib76","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1359\/jbmr.1997.12.12.1959","article-title":"Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells","volume":"12","author":"House","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib77","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199507203330307","article-title":"Renal osteodystrophy","volume":"333","author":"Hruska","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib78","doi-asserted-by":"crossref","first-page":"46622","DOI":"10.1074\/jbc.M207100200","article-title":"Identification of acidic residues in the extracellular loops of the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+ and a positive allosteric modulator","volume":"277","author":"Hu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib79","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000168681","article-title":"Histological, radiological, and biochemical features of the adynamic bone lesion in continuous ambulatory peritoneal dialysis patients","volume":"14","author":"Hutchison","year":"1994","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib80","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1507\/endocrj.47.517","article-title":"Effect of calcimimetic agent, KRN568, on gastrin secretion in healthy subjects","volume":"47","author":"Igarashi","year":"2000","journal-title":"Endocr J"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib81","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI10523","article-title":"Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice","volume":"107","author":"Imanishi","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib82","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S8756-3282(99)00263-X","article-title":"Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia","volume":"26","author":"Ishii","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib83","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jbmr.5650050712","article-title":"Regulation by calcium and 1,25-(OH)2D3 of cell proliferation and function of bovine parathyroid cells in culture","volume":"5","author":"Ishimi","year":"1990","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib84","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s002239900617","article-title":"Relationship between Ca-dependent change of serum PTH and extracellular Ca2+-sensing receptor expression in parathyroid adenoma","volume":"64","author":"Kaneko","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib85","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJM197705122961901","article-title":"Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis","volume":"296","author":"Kanis","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib86","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.bmcl.2004.03.056","article-title":"N2-benzyl-N1-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor","volume":"14","author":"Kessler","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib87","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1210\/jc.81.4.1598","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib88","doi-asserted-by":"crossref","first-page":"F291","DOI":"10.1152\/ajprenal.2001.280.2.F291","article-title":"Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells","volume":"280","author":"Kifor","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib89","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2002-020249","article-title":"A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor","volume":"88","author":"Kifor","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib90","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0169-6009(91)90029-Y","article-title":"Effects of continuous infusion of parathyroid hormone and parathyroid hormone-related peptide on rat bone in vivo: comparative study by histomorphometry","volume":"12","author":"Kitazawa","year":"1991","journal-title":"Bone Miner"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib91","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM198706183162504","article-title":"Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure","volume":"316","author":"Korkor","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib92","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1172\/JCI17416","article-title":"The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone","volume":"111","author":"Kos","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib93","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/endo-125-2-935","article-title":"Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells","volume":"125","author":"Kremer","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib94","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1126\/science.279.5357.1722","article-title":"Structural basis for a Ca2+-sensing function of the metabotropic glutamate receptors","volume":"279","author":"Kubo","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib95","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1124\/dmd.104.000604","article-title":"Metabolism and disposition of calcimimetic agent cinacalcet HCl in humans and animal models","volume":"32","author":"Kumar","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib96","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Evidence for abnormal calcium homeostasis in patients with adynamic bone disease","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib97","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0009-9236(99)70120-7","article-title":"Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568","volume":"65","author":"Lalonde","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib98","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/endo-113-1-277","article-title":"Abnormal regulation of parathyroid cell secretion and proliferation in primary cultures of bovine parathyroid cells","volume":"113","author":"LeBoff","year":"1983","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib99","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1097\/01.ASN.0000024439.38838.03","article-title":"Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation","volume":"13","author":"Lewin","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib100","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1172\/JCI118513","article-title":"Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism","volume":"97","author":"Li","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib101","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1523-1755.1998.00786.x","article-title":"Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure","volume":"53","author":"Liang","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib102","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ndt\/gfh829","article-title":"Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism","volume":"20","author":"Lien","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib103","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1523-1755.2003.00720.x","article-title":"The calcimimetic AMG 073 reduces parathyroid hormone and calcium\u00d7phosphorus in secondary hyperparathyroidism","volume":"63","author":"Lindberg","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib104","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib105","series-title":"The Kidney","first-page":"2103","article-title":"Renal osteodystrophy","author":"Llach","year":"1996"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib106","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib107","doi-asserted-by":"crossref","first-page":"F432","DOI":"10.1152\/ajprenal.1990.259.3.F432","article-title":"Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol","volume":"259","author":"Lopez-Hilker","year":"1990","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib108","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1210\/en.138.9.3601","article-title":"Stimulation of cell proliferation by calcium and a calcimimetic compound","volume":"138","author":"Mailland","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib109","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ki.1990.187","article-title":"Renal bone disease 1990: an unmet challenge for the nephrologist","volume":"38","author":"Malluche","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib110","series-title":"ERA-EDTA XLI Congress Abstract Book","first-page":"218","article-title":"Cinacalcet HCl reduces bone turnover and bone marrow fibrosis in hemodialysis patients with secondary hyperparathyroidism (HPT)","author":"Malluche","year":"2004"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2005.06.019_bib111","doi-asserted-by":"crossref","first-page":"i9","DOI":"10.1093\/ndt\/gfh1002","article-title":"The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?","volume":"19","author":"Malluche","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib112","first-page":"219","article-title":"Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia","volume":"14","author":"Massry","year":"1994","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib113","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ki.1980.154","article-title":"Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy","volume":"18","author":"Massry","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib114","first-page":"160","article-title":"Calcific uremic arteriolopathy in association with low turnover uremic bone disease","volume":"52","author":"Mawad","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib115","doi-asserted-by":"crossref","first-page":"49691","DOI":"10.1074\/jbc.M205578200","article-title":"Calcium sensing receptor activation by a calcimimetic suggests a link between cooperativity and intracellular calcium oscillations","volume":"277","author":"Miedlich","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib116","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1074\/jbc.M307191200","article-title":"Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site","volume":"279","author":"Miedlich","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib117","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1210\/en.136.7.2954","article-title":"Spontaneous oscillations of intracellular calcium in single bovine parathyroid cells may be associated with the inhibition of parathyroid hormone secretion","volume":"136","author":"Miki","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib118","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.136.7.3087","article-title":"The reduced responsiveness of cultured bovine parathyroid cells to extracellular Ca2+ is associated with marked reduction in the expression of extracellular Ca2+-sensing receptor messenger ribonucleic acid and protein","volume":"136","author":"Mithal","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib119","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1097\/01.ASN.0000141016.20133.33","article-title":"Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency","volume":"15","author":"Mizobuchi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000073945","article-title":"Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product","volume":"23","author":"Moe","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib121","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI\u2122 bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib122","doi-asserted-by":"crossref","first-page":"F399","DOI":"10.1152\/ajprenal.00346.2001","article-title":"Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs","volume":"283","author":"Motoyama","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib123","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0003-9861(88)90378-5","article-title":"Regulation of hormone secretion and cytosolic Ca2+ by extracellular Ca2+ in parathyroid cells and C-cells: role of voltage-sensitive Ca2+ channels","volume":"265","author":"Muff","year":"1988","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s101570070004","article-title":"Pharmacological properties of the calcimimetic compound NPS R-568 in vitro and in vivo","volume":"4","author":"Murakami","year":"2000","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib125","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1097\/00003246-200012000-00024","article-title":"Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: a potential contributory factor to postburn hypocalcemia","volume":"28","author":"Murphey","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib126","first-page":"71","article-title":"Drugs inhibiting parathyroid hormone (PTH) secretion by control of the calcium receptor (calcimimetics): effect on the set point of calcium-regulated PTH secretion","volume":"15","author":"Nagano","year":"2005","journal-title":"Clin Calcium"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib127","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1254\/jphs.FMJ04007X6","article-title":"Functional proteins involved in regulation of intracellular Ca2+ for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics","volume":"97","author":"Nagano","year":"2005","journal-title":"J Pharmacol Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2005.06.019_bib128","first-page":"S222","article-title":"Simultaneous activation of parathyroid and renal calcium receptor by a calcimimetic compound produces similar clinical observations to autosomal dominant hypocalcemia (ADH): experimental animal model of ADH","volume":"14","author":"Nagano","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000046093","article-title":"Renal mineral handling in normal rats treated with sevelamer hydrochloride (Renagel\u00ae), a noncalcemic phosphate binder","volume":"89","author":"Nagano","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib130","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/ndt\/16.9.1870","article-title":"Sevelamer hydrochloride (Renagel\u00ae), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency","volume":"16","author":"Nagano","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2005.06.019_bib131","first-page":"iii81","article-title":"Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats","volume":"18","author":"Nagano","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib132","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/ndt\/gfg309","article-title":"Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency","volume":"18","author":"Nagano","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2005.06.019_bib133","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines: bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib134","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0272-6386(99)70106-X","article-title":"Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients","volume":"34","author":"Navarro","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib135","first-page":"373","article-title":"Magnesium in dialysis patients: serum levels and clinical implications","volume":"49","author":"Navarro-Gonzalez","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib136","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats: the effects of calcium, phosphate, and vitamin D","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib137","series-title":"Principles of Bone Biology","first-page":"1019","article-title":"Calcium receptors as novel drug targets","author":"Nemeth","year":"1996"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib138","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2174\/1381612023393387","article-title":"Pharmacological regulation of parathyroid hormone secretion","volume":"8","author":"Nemeth","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib139","doi-asserted-by":"crossref","first-page":"E505","DOI":"10.1152\/ajpendo.1989.257.4.E505","article-title":"Adenine nucleotides mobilize cellular Ca2+ and inhibit parathyroid hormone secretion","volume":"257","author":"Nemeth","year":"1989","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-5793(86)81427-2","article-title":"Cytosolic Ca2+ and the regulation of secretion in parathyroid cells","volume":"203","author":"Nemeth","year":"1986","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib141","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1016\/S0021-9258(18)61172-X","article-title":"Rapid mobilization of cellular Ca2+ in bovine parathyroid cells evoked by extracellular divalent cations: evidence for a cell surface calcium receptor","volume":"262","author":"Nemeth","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib142","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/S0021-9258(17)35839-8","article-title":"Stimulus-secretion coupling in bovine parathyroid cells: dissociation between secretion and net changes in cytosolic Ca2+","volume":"261","author":"Nemeth","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib143","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","article-title":"Calcimimetics with potent and selective activity on the parathyroid calcium receptor","volume":"95","author":"Nemeth","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib144","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib145","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/oxfordjournals.ndt.a027665","article-title":"A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells","volume":"11","author":"Nielsen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib146","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1006\/bbrc.1997.7207","article-title":"Inhibition of PTH secretion by interleukin-1\u03b2 in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA","volume":"238","author":"Nielsen","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib147","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.ASN.0000056188.23717.E5","article-title":"Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors","volume":"14","author":"Ogata","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib148","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2125.2004.02088.x","article-title":"The calcimimetic agent KRN1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis","volume":"57","author":"Ohashi","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib149","doi-asserted-by":"crossref","first-page":"21903","DOI":"10.1016\/S0021-9258(18)54722-0","article-title":"Negative regulatory elements in the human parathyroid hormone gene","volume":"266","author":"Okazaki","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib150","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1523-1755.2005.00156.x","article-title":"Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats","volume":"67","author":"Oste","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib151","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa040008","article-title":"Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor","volume":"351","author":"Pallais","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib152","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ki.1997.297","article-title":"The hyperparathyroidism of chronic renal failure: a disorder of growth","volume":"52","author":"Parfitt","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib153","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","article-title":"Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry","volume":"12","author":"Parfitt","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib154","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1523-1755.2004.00564.x","article-title":"Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat","volume":"65","author":"Pattaragarn","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib156","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib157","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1359\/jbmr.040114","article-title":"A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium","volume":"19","author":"Pi","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib158","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1074\/jbc.275.5.3256","article-title":"Sensing of extracellular cations in CaSR-deficient osteoblast. Evidence for a novel cation-sensing mechanism","volume":"275","author":"Pi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib159","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1210\/en.2002-220240","article-title":"Calcium-sensing receptor activation of Rho involves filamin and Rho-guanine nucleotide exchange factor","volume":"143","author":"Pi","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib160","first-page":"57","article-title":"Fractures and vertebral bone mineral density in patients with renal osteodystrophy","volume":"30","author":"Piraino","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib161","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib162","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng1194-303","article-title":"Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation","volume":"8","author":"Pollak","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib163","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00005792-199605000-00001","article-title":"Three inherited disorders of calcium sensing","volume":"75","author":"Pollak","year":"1996","journal-title":"Medicine"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib164","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00041552-200307000-00002","article-title":"Extracellular calcium-sensing receptors in the parathyroid gland, kidney, and other tissues","volume":"12","author":"Quarles","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib165","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1359\/jbmr.1997.12.3.393","article-title":"A distinct cation-sensing mechanism in MC3T3-E1 osteoblasts functionally related to the calcium receptor","volume":"12","author":"Quarles","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib166","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","article-title":"The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease","volume":"14","author":"Quarles","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib167","doi-asserted-by":"crossref","first-page":"37241","DOI":"10.1074\/jbc.M404520200","article-title":"pH sensing by the calcium-sensing receptor","volume":"279","author":"Quinn","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib168","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF03343826","article-title":"Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk?","volume":"24","author":"Rao","year":"2001","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib169","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF03343810","article-title":"Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk?","volume":"24","author":"Rastad","year":"2001","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib170","doi-asserted-by":"crossref","first-page":"18908","DOI":"10.1074\/jbc.M202113200","article-title":"Evidence for distinct cation and calcimimetic compound (NPS 568) recognition domains in the transmembrane regions of the human Ca2+ receptor","volume":"277","author":"Ray","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib171","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1172\/JCI119413","article-title":"Expression of the calcium-sensing receptor on human antral gastrin cells in culture","volume":"99","author":"Ray","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib172","doi-asserted-by":"crossref","first-page":"F951","DOI":"10.1152\/ajprenal.1996.271.4.F951","article-title":"Localization of the extracellular Ca2+-sensing receptor and PTH\/PTHrP receptor in rat kidney","volume":"271","author":"Riccardi","year":"1996","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib173","doi-asserted-by":"crossref","first-page":"F611","DOI":"10.1152\/ajprenal.1998.274.3.F611","article-title":"Localization of the extracellular Ca2+\/polyvalent cation-sensing protein in rat kidney","volume":"274","author":"Riccardi","year":"1998","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib174","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1046\/j.1523-1755.2001.00027.x","article-title":"Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor","volume":"60","author":"Ritter","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib175","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1359\/jbmr.2002.17.12.2206","article-title":"Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function","volume":"17","author":"Ritter","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib176","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/en.136.2.499","article-title":"Calcium receptor messenger ribonucleic acid levels in the parathyroid glands and kidney of vitamin D-deficient rats are not regulated by plasma calcium or 1,25-dihydroxyvitamin D3","volume":"136","author":"Rogers","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib177","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/BF02935679","article-title":"Parathyroid gland calcium receptor mRNA levels are unaffected by chronic renal insufficiency or low dietary calcium in rats","volume":"3","author":"Rogers","year":"1995","journal-title":"Endocrine"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib178","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib179","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1365-2362.2001.00809.x","article-title":"Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate","volume":"31","author":"Roussanne","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1525-1381.1999.09866.x","article-title":"A novel calcium sensor stimulating inositol phosphate formation and [Ca2+]i signaling expressed by GCT23 osteoclast-like cells","volume":"111","author":"Seuwen","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib181","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1615\/CritRevEukaryotGeneExpr.v13.i24.30","article-title":"In vitro studies with the calcimimetic, cinacalcet HCl, on normal human adult osteoblastic and osteoclastic cells","volume":"13","author":"Shalhoub","year":"2003","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib182","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1681\/ASN.V1341124","article-title":"Editorials. Manipulating the calcium receptor","volume":"13","author":"Sherrard","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib183","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure: an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib184","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1681\/ASN.2004030236","article-title":"Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats","volume":"16","author":"Shiizaki","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib185","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1210\/jc.2002-021597","article-title":"The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism","volume":"88","author":"Shoback","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib186","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00061.2002","article-title":"Mechanisms of secondary hyperparathyroidism","volume":"283","author":"Silver","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib187","first-page":"460A","article-title":"The calcimimetic R-568 markedly decreases PTH mRNA levels in rats with secondary hyperparathyroidism due to experimental uremia","volume":"14","author":"Silver","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib188","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199711203372104","article-title":"Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism","volume":"337","author":"Silverberg","year":"1997","journal-title":"N Engl J Med"},{"issue":"Suppl. 8","key":"10.1016\/j.pharmthera.2005.06.019_bib189","first-page":"viii7","article-title":"The cardio-renal anaemia syndrome: does it exist?","volume":"18","author":"Silverberg","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s007740050067","article-title":"Identification of novel signaling pathways during functional adaptation of the skeleton to mechanical loading: the role of glutamate as a paracrine signaling agent in the skeleton","volume":"17","author":"Skerry","year":"1999","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib191","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth: high phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib192","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00000441-199906000-00004","article-title":"The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure","volume":"317","author":"Slatopolsky","year":"1999","journal-title":"Am J Med Sci"},{"issue":"Suppl. 80","key":"10.1016\/j.pharmthera.2005.06.019_bib193","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1046\/j.1523-1755.61.s80.24.x","article-title":"Control of uremic bone disease: role of vitamin D analogs","volume":"61","author":"Slatopolsky","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib194","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1046\/j.1523-1755.1999.00432.x","article-title":"Aluminum is a weak agonist for the calcium-sensing receptor","volume":"55","author":"Spurney","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib195","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.1989.89","article-title":"1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia","volume":"35","author":"Szabo","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib196","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1677\/jme.0.0310609","article-title":"Parathyroid hormone (PTH) secretion, PTH mRNA and calcium-sensing receptor mRNA expression in equine parathyroid cells, and effects of interleukin (IL)-1, IL-6, and tumor necrosis factor-\u03b1 on equine parathyroid cell function","volume":"31","author":"Toribio","year":"2003","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib197","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib198","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI200317054","article-title":"Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background","volume":"111","author":"Tu","year":"2003","journal-title":"J Clin Invest"},{"issue":"Suppl. 5","key":"10.1016\/j.pharmthera.2005.06.019_bib199","doi-asserted-by":"crossref","first-page":"v27","DOI":"10.1093\/ndt\/gfh1053","article-title":"Clinical experience with cinacalcet HCl","volume":"19","author":"Urena Torres","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib200","doi-asserted-by":"crossref","first-page":"F925","DOI":"10.1152\/ajprenal.1997.273.6.F925","article-title":"Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure","volume":"273","author":"Vaziri","year":"1997","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib201","doi-asserted-by":"crossref","first-page":"F642","DOI":"10.1152\/ajprenal.1998.274.4.F642","article-title":"Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH","volume":"274","author":"Vaziri","year":"1998","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib202","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/archinte.143.6.1205","article-title":"The effects of calciferol and its metabolites on patients with chronic renal failure: II. Calcitriol, 1\u03b1-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3","volume":"143","author":"Voigts","year":"1983","journal-title":"Arch Inter Med"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ki.1984.37","article-title":"Parathyroid hormone and bone histology: response to hypocalcemia in osteitis fibrosa","volume":"25","author":"Voigts","year":"1984","journal-title":"Kidney Int"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2005.06.019_bib204","first-page":"iii13","article-title":"Control of parathyroid cell growth by calcimimetics","volume":"18","author":"Wada","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib205","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1172\/JCI119851","article-title":"The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency: control of parathyroid cell growth via a calcium receptor","volume":"100","author":"Wada","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib206","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","article-title":"NPS R-568 halts or reverses osteitis fibrosa in uremic rats","volume":"53","author":"Wada","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib207","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1523-1755.2000.00837.x","article-title":"Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism","volume":"57","author":"Wada","year":"2000","journal-title":"Kidney Int"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2005.06.019_bib208","first-page":"S99","article-title":"The calcimimetic compound, cinacalcet HCl, ameliorates osteitis fibrosa in rats with chronic renal insufficiency","volume":"18","author":"Wada","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib209","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1210\/en.137.11.4558","article-title":"Parathyroid cell proliferation in the rat: effect of age and of phosphate administration and recovery","volume":"137","author":"Wang","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF02509544","article-title":"Phosphate administration increases both size and number of parathyroid cells in adult rats","volume":"58","author":"Wang","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib211","doi-asserted-by":"crossref","first-page":"14476","DOI":"10.1074\/jbc.273.23.14476","article-title":"Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro","volume":"273","author":"Ward","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF02411202","article-title":"Decreased mineralization in hemodialysis patients after subtotal parathyroidectomy","volume":"34","author":"Weinstein","year":"1982","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib213","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jemt.1070320208","article-title":"Quantitative and three-dimensional aspects of the rat parathyroid gland in normo-, hypo-, and hypercalcemia","volume":"32","author":"Wernerson","year":"1995","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib214","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0028-3908(99)00119-7","article-title":"Calcium sensing properties of the GABAB receptor","volume":"38","author":"Wise","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib215","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/en.139.8.3561","article-title":"Extracellular calcium (Ca2+o)-sensing receptor in a murine bone marrow-derived stromal cell line (ST2): potential mediator of the actions of Ca2+o on the function of ST2 cells","volume":"139","author":"Yamaguchi","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib216","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1359\/jbmr.1998.13.10.1530","article-title":"Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells","volume":"13","author":"Yamaguchi","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib217","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1006\/bbrc.1998.8648","article-title":"Expression of extracellular calcium (Ca2+o)-sensing receptor in human peripheral blood monocytes","volume":"246","author":"Yamaguchi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib218","doi-asserted-by":"crossref","first-page":"C382","DOI":"10.1152\/ajpcell.2001.280.2.C382","article-title":"Expression of extracellular calcium-sensing receptor in human osteoblastic MG-63 cell line","volume":"280","author":"Yamaguchi","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib219","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1172\/JCI113946","article-title":"Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat","volume":"83","author":"Yamamoto","year":"1989","journal-title":"J Clin Invest"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2005.06.019_bib220","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib221","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the dialysis outcomes and practice patterns study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib222","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI118197","article-title":"A ryanodine receptor-like molecule expressed in the osteoclast plasma membrane functions in extracellular Ca2+ sensing","volume":"96","author":"Zaidi","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.019_bib223","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1359\/jbmr.1999.14.5.669","article-title":"Emerging insights into the role of calcium ions in osteoclast regulation","volume":"14","author":"Zaidi","year":"1999","journal-title":"J Bone Miner Res"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372580500152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372580500152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T16:01:52Z","timestamp":1735920112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372580500152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":223,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S016372580500152X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.06.019","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}